BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21458936)

  • 1. [Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
    Manga NM; Poda A; Bazolo N; Sané O; Batista G; Guèye NF; Sow PS; Badiane CI
    Med Mal Infect; 2011 Jul; 41(7):390-1. PubMed ID: 21458936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polyarthritis and papular eruption revealing leprosy].
    Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
    Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 5. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 6. Borderline tuberculoid leprosy with type 1 reaction in an HIV patient--a phenomenon of immune reconstitution.
    Narang T; Dogra S; Kaur I
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):203-5. PubMed ID: 16830642
    [No Abstract]   [Full Text] [Related]  

  • 7. An unusual presentation of facial palsy in leprosy; a case report.
    Thompson K
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):567-9. PubMed ID: 8642221
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe ototoxicity in a health care worker who received postexposure prophylaxis with stavudine, lamivudine, and nevirapine after occupational exposure to HIV.
    Rey D; L'Héritier A; Lang JM
    Clin Infect Dis; 2002 Feb; 34(3):418-9. PubMed ID: 11774091
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of Hansen Disease presenting as tinea versicolor.
    Yang S; Makredes M; O'Donnell P; Levin NA
    Dermatol Online J; 2013 Apr; 19(4):7. PubMed ID: 24021367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing countries need better antiretroviral drugs.
    Mykén N; Sundbeck B; Mpumilwa G; Andersson R
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):23-4. PubMed ID: 19171914
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 12. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
    Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune reconstitution inflammatory syndrome or upgrading type 1 reaction? Report of two AIDS patients presenting a shifting from borderline lepromatous leprosy to borderline tuberculoid leprosy.
    Talhari C; Ferreira LC; Araújo JR; Talhari AC; Talhari S
    Lepr Rev; 2008 Dec; 79(4):429-35. PubMed ID: 19274990
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
    Cournil A; Coudray M; Kouanfack C; Essomba CN; Tonfack CA; Biwolé-Sida M; Delaporte E; Bork K; Laurent C
    Antivir Ther; 2010; 15(7):1039-43. PubMed ID: 21041920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons.
    Martiniuk F; Rao SD; Rea TH; Glickman MS; Giovinazzo J; Rom WN; Cabrera A; Levis WR
    Emerg Infect Dis; 2007 Sep; 13(9):1438-40. PubMed ID: 18252138
    [No Abstract]   [Full Text] [Related]  

  • 17. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A treatment in reversal reaction.
    Chin-A-Lien RA; Faber WR; Naafs B
    Trop Geogr Med; 1994; 46(2):123-4. PubMed ID: 8079388
    [No Abstract]   [Full Text] [Related]  

  • 19. Smear positive leprosy with HIV infection, silent neuritis and extensive tinea corporis and tinea unguium in an Indian male.
    Mendiratta VR; Sharma RC; Sardana K; Koranne RV
    Indian J Lepr; 2001; 73(4):349-52. PubMed ID: 11898467
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.